Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Vildagliptin is a cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Vildagliptin's cyano moiety undergoes hydrolysis and this inactive metabolite is excreted mainly via the urine.
Description | Vildagliptin is a cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Vildagliptin's cyano moiety undergoes hydrolysis and this inactive metabolite is excreted mainly via the urine. |
Targets&IC50 | DPP-4:2.3 nM |
Synonyms | LAF237, 维达列汀, 维格列汀, NVP-LAF 237 |
Molecular Weight | 303.406 |
Formula | C17H25N3O2 |
CAS No. | 274901-16-5 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Ethanol: 56 mg/mL (184.6 mM)
DMSO: 56 mg/mL (184.6 mM)
H2O: 55 mg/mL (181.3 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Vildagliptin 274901-16-5 蛋白酶体 凋亡 泛素化 细胞周期 Apoptosis DPP-4 Ferroptosis Proteasome Dipeptidyl Peptidase Inhibitor peptidase Caco-2 cells LAF237 dipeptidyl LAF 237 DPP-IV antihyperglycemic NVP-LAF 237 DPP LAF-237 inhibit inhibitor